Sage Journals: Discover world-class research

Open access

Research article

First published 2026

Clinical Analysis of Peripheral Blood Indicators for Immune-Related Adverse Events (irAEs) in Patients With Advanced Lung Cancer

Yin-Min Ji, Yu-hui Qin, Ya-Hui Lv [...]

Clinical Medicine Insights: Oncology

Retricted access

Review article

First published 2021-1

Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management

Anastasiya Muntyanu, Elena Netchiporouk, William Gerstein [...]

Journal of Cutaneous Medicine and Surgery

Retricted access

Research article

First published 2021-10

Assessment of hospitalization rates for immune-related adverse events with immune checkpoint inhibitors

Laura Nice, Ryan Bycroft, Xiaoyong Wu [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2023

Development of an eHealth Tool for Capturing and Analyzing the Immune-related Adverse Events (irAEs) in Cancer Treatment

Saeed Moradian, Shive Ghasemi, Babak Boutorabi [...]

Cancer Informatics

Retricted access

Research article

First published 2024-10

Utilization and toxicity patterns of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and metastatic melanoma at BC cancer

Jennifer Truong, Shirley S.T. Yeung, Victoria Kletas [...]

Journal of Oncology Pharmacy Practice

Open access

Case report

First published 2022

Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab,a case report

Maria d’Apolito, Rocco Spagnuolo, Maria Anna Siciliano [...]

Sage Open Chronic Disease

Open access

Letter

First published 2022-1

Reader Comment Regarding “Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management”

Maxwell Sauder, Marcus Butler

Journal of Cutaneous Medicine and Surgery

Retricted access

Case report

First published 2026

Toxic epidermal necrolysis during chemo-immunotherapy treatment with pembrolizumab

Araceli Iglesias-Santamaría, Nerea Rodríguez González

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2025-10

Sjogren's syndrome due to immune checkpoint inhibitors (ICIs): Insights from a single-institution series and systematic review of the literature

Abram Soliman, Ruba Hassan, Ion Codreanu [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2023-2

Acute kidney injury (AKI) post-mRNA SARS-CoV-2 vaccine in patients with cancer,treated with immune check point inhibitor (ICPi): An immune double whammy!

Richard Baker, Kinjal Gosalia, Kenar D Jhaveri [...]

Journal of Onco-Nephrology

Search results